Does having a COVID-19 service in the hospital affect the anxiety state and preferences of patients applying to the urology outpatient clinic
DOI:
https://doi.org/10.18203/2349-2902.isj20253010Keywords:
Anxiety, Bladder tumor, COVID-19, Prostate cancerAbstract
Background: Our aim is to investigate the effect of having a COVİD-19 service in the hospital on the anxiety level of patients applying to the urology outpatient clinic and the number of patients admitted.
Methods: The study was designed as a prospective cohort study. We divided the patients into Group-1 (hospital with a COVID 19 service) and Group-2 (hospital without a COVID-19 service). State Anxiety was used to determine the anxiety status of patients in Group-1 and Group-2. Scale (STAI-I) was used. Patients were interviewed face to face. Our hospital has a COVID-19 service. The purpose of the research was explained in detail. An average interview lasted 10-15 minutes. After the data were obtained, Group-1 and Group-2 were compared in terms of anxiety, age, gender and reason for applying to the hospital.
Results: The total number of patients is 313, 92 of these patients agreed to participate in the survey. The number of patients in Group 1 and Group 2 is 33 and 59, respectively. Median age is in Group 1 and Group 2, respectively. 53.03±15.98 and 47.53±15.8 (mean±SD). When we look at it in terms of anxiety, we found that the presence of the COVİD service negatively affected the psychological state of the patients. 96% (58/60) of the patients with severe anxiety applied to the urology outpatient clinic of the hospital without a COVID service (p=0.001). According to the results of multivariate analysis patients who need to start their treatment as soon as possible are more likely to apply to the urology clinic of hospitals that do not have a COVİD-19 service (odds ratio (OR): 1.284, 95% confidence interval (CI): 1.051–1.567, p=0.014).
Conclusions: We believe that in future epidemic situations, separating specialized hospitals for infected patients will be more efficient both for managing the epidemic and for oncology patients.
Metrics
References
Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MU, Khan K. Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med. 2020;27:38. DOI: https://doi.org/10.1093/jtm/taaa008
Chiluba BC, Dube G. Descriptive review of epidemiological geographic mapping of coronavirus disease 2019 (COVID-19) on the internet. Biomed Biotechnol Res J. 2020;4(2):83-9. DOI: https://doi.org/10.4103/bbrj.bbrj_50_20
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. DOI: https://doi.org/10.1001/jama.2020.1585
HuiDS, Azhar EI, MadaniTA. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020; 91: 264–6. DOI: https://doi.org/10.1016/j.ijid.2020.01.009
He F, Deng Y, Li W. Coronavirus disease 2019: What we know. J Med Virol. 2020;92(7):719-25. DOI: https://doi.org/10.1002/jmv.25766
World Health Organization. Coronavirus disease 2019 (COVID-19). Situation Report. Available at: https://www.who.int/docs/default-source/coronaviruse. Accessed on 20 March 2025.
Kupferschmidt K, Cohen J. China’s COVID-19 strategy work elsewhere. Science. 2020;367:1061–2. DOI: https://doi.org/10.1126/science.367.6482.1061
Gostin LO, Hodge JG, Wiley LF. Presidential powers and response to COVID-19. JAMA. 2020. DOI: https://doi.org/10.1001/jama.2020.4335
Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, Sun J, Chang C. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimm. 2020;109:102434. DOI: https://doi.org/10.1016/j.jaut.2020.102434
Showghi NN, Williams AC. Information about male chronic pelvic and urogenital pain on the internet: an evaluation of internet resources. Pain Med. 2012;13(10):1275-83. DOI: https://doi.org/10.1111/j.1526-4637.2012.01466.x
Wolf Jr JS. Science & Quality Council Update. AUANews. 2016;21(6):65.
Chan MC, Yeo SE, Chong YL, Lee YM. Stepping forward: urologists’ efforts during the COVID-19 outbreak in Singapore. European Urol. 2020;78(1):38-9. DOI: https://doi.org/10.1016/j.eururo.2020.03.004
Rimmer A. Trainees and covid-19: your questions answered. BMJ. 2020;368:1059. DOI: https://doi.org/10.1136/bmj.m1059
Travassos TC, Oliveira JMİ, Selegatto İB, Reis RO. COVID-19 impact on bladder cancer-orientations for diagnosing, decision making and treatment. Am J Clin Exp Urol. 2021;15;9(1):132-9.
Faris A, Herrel H, Montie JE. Urologic oncology patient perspectives during COVID-19 treatment delays. Support Care Canc. 2022;30(8):7015-20. DOI: https://doi.org/10.1007/s00520-022-07028-z
Tachibana I, Ferguson EL, Mahenthiran A. Delaying cancer cases in urology during COVID-19: review of the literature. J Urol. 2020;204(5):926-33. DOI: https://doi.org/10.1097/JU.0000000000001288
Luo M, Guo L, Yu M, Jiang W, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public-A systematic review and meta-analysis. Psychiatry Res. 2020;291:11319. DOI: https://doi.org/10.1016/j.psychres.2020.113190
Downloads
Published
How to Cite
Issue
Section
